Progenika Biopharma presents a biochip that guarantees safety in blood transfusions

July 04, 2007

The Basque biotechnology company, Progenika Biopharma, devoted to research and development in personalised medicine, have presented a DNA biochip, known as BLOODchip, which greatly eliminates the risk of adverse reactions due to incompatibility in blood groups between donor and receptor in blood transfusions.

With the aim of guaranteeing safety during blood transfusions, Progenika has developed and validated 1,000 clinical samples in cooperation with the principal European blood banks. Concretely, the validation of these samples was 99.8%, considerably higher than that produced using the current serology technique, which produces an error of 3%.

Thus, BLOODchip is currently the safest and most precise technique for genetically determining blood groups, enabling the reduction of adverse reactions in blood transfusions.

Two different techniques are currently used to detect possible incompatibilities in blood transfusions: the serological method and DNA sequencing. The serological technique has a limited capacity and does not allow the detection of 3% of the incompatibilities existing. DNA sequencing, while overcoming this drawback of the serological method, is however a slow and costly system.

Progenika has developed BLOODchip to respond to the disadvantages of the current systems. In this way, the totality of blood group incompatibilities are detected in a safer, quicker and more specific analytical process than with the serological technique. Moreover, its cost is twenty times less than DNA sequencing, which enables its generalized and routine use in all blood transfusions.

The BLOODchip is the result of research within the remit of the European Union IV Framework Programme and undertaken by Progenika in collaboration with the principal European blood banks.

It should be pointed out that Progenika Biopharma has developed and patented various products that are already on the market for several types of diagnosis (for diagnoses, prognoses and the prediction of and response to treatment of human diseases). So, in 2004 Progenika launched the LIPOchip on to the market, for the diagnosis of Family Hypercholesterolemia, the first biochip with the CE label and on sale since 2004. Progenika currently has 3 products that are at a development phase and which will finalise at the end of the year.
-end-
Progenika has managed to become the international technological leader in the field of developing genetic biochips. Biochips enable the simultaneous analysis of genetic variables, multiplying the capacity of conventional techniques for the diagnosis of illness, prognosticating its aggressiveness and progression and predicting the response of the patient to treatment.

Elhuyar Fundazioa

Related DNA Sequencing Articles from Brightsurf:

World's largest DNA sequencing of Viking skeletons reveals they weren't all Scandinavian
Invaders, pirates, warriors - the history books taught us that Vikings were brutal predators who travelled by sea from Scandinavia to pillage and raid their way across Europe and beyond.

New DNA sequencing technique may help unravel genetic diversity of cancer tumors
Understanding the genetic diversity of individual cells within a cancer tumor and how that might impact the disease progression has remained a challenge, due to the current limitations of genomic sequencing.

Patient-personalized sequencing pipeline steps up sensitivity of tumor DNA monitoring
A sequencing pipeline that integrates a patient's specific tumor genetic data boosts the sensitivity of tests that detect cancer cell DNA circulating in the blood, according to a newly published study.

Some genetic sequencing fail to analyze large segments of DNA
Children who undergo expansive genetic sequencing may not be getting the thorough DNA analysis their parents were expecting, say experts at UT Southwestern Medical Center.

Carolina parakeet extinction was driven by human causes, DNA sequencing reveals
Researchers from the Institute of Evolutionary Biology, a joint institute of the Pompeu Fabra University and the Spanish National Research Council, and the Globe Institute (University of Copenhagen), have unveiled the genome of the Carolina parakeet, extinct at the beginning of the 20th century.

Targeting DNA sequencing for plant biodiversity research
High-throughput sequencing is revolutionizing research in plant evolutionary biology. Using third-generation sequencing technologies, researchers are able to target long fragments of chloroplast DNA to improve genome assembly.

Massive sequencing study links rare DNA alterations to type 2 diabetes
An international consortium of scientists has analyzed protein-coding genes from nearly 46,000 people, linking rare DNA alterations to type 2 diabetes.

Astronaut twins study yields new insights and portable DNA sequencing tools
Long-term spaceflight causes more changes to gene expression than shorter trips, especially to the immune system and DNA repair systems, according to research by Weill Cornell Medicine and NASA investigators as part of NASA's Twins Study, which followed the only set of identical twin astronauts for more than a year.

A new sequencing method to detect DNA modifications of relevance to cancer
Ludwig Cancer Research scientists report in the current issue of Nature Biotechnology a new and improved method to detect chemical modifications to DNA.

Sequencing pollen DNA to discover insect migratory routes
Metabarcoding, a technique of mass DNA sequencing, allows for tracing migratory routes of insects, an understudied subject due to technical limitations.

Read More: DNA Sequencing News and DNA Sequencing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.